Full text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

The management of chronic diseases in the midst of the COVID-19 pandemic is especially challenging, and reducing potential psychological harm is essential. This review aims to determine the prevalence of depression during the COVID-19 pandemic in patients with chronic disease, and to characterize the impacts of related factors. A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The meta-analysis was performed using StatsDirect software. The review identified 33 articles with a total of 50,905 patients with chronic diseases. Four meta-analyses were performed to estimate the prevalence of depression. In diabetic patients, the prevalence ranged from 17% (95% CI = 7–31) (PHQ-9) to 33% (95% CI = 16–51) (PHQ-8); in obese patients, the prevalence was 48% (95% CI = 26–71); and in hypertensive patients, the prevalence was 18% (95% CI = 13–24). The factors significantly associated with depression were female sex, being single, deterioration in the clinical parameters of diabetes, a decrease in self-care behavior, reduced physical activity and sleep time and fear of contagion. The COVID-19 pandemic has significantly increased levels of depression among persons with chronic disease. Pandemics and other emergency events have a major impact on mental health, so early psychological interventions and health management policies are needed to reinforce chronic patients’ physical and mental health.

Details

Title
Prevalence of Depression and Related Factors among Patients with Chronic Disease during the COVID-19 Pandemic: A Systematic Review and Meta-Analysis
Author
García-Lara, Rubén A 1 ; Suleiman-Martos, Nora 2   VIAFID ORCID Logo  ; Membrive-Jiménez, María J 3   VIAFID ORCID Logo  ; García-Morales, Victoria 4   VIAFID ORCID Logo  ; Quesada-Caballero, Miguel 5 ; Guisado-Requena, Isabel M 6   VIAFID ORCID Logo  ; Gómez-Urquiza, José L 7   VIAFID ORCID Logo 

 UGC Orgiva, Granada-South Health Management Area, Andalusian Health Service, Calle La Madre s/n, Lanjarón, 18420 Granada, Spain 
 Nursing Department, Faculty of Health Sciences, University of Granada, Av. de la Ilustración, 60, 18016 Granada, Spain 
 Red Cross Nursing Center, University of Sevilla, Av. la Cruz Roja, 41009 Sevilla, Spain 
 Department of Biomedicine, Biotechnology and Public Health, Faculty of Medicine, University of Cadiz, Pl. Falla, 9, 11003 Cadiz, Spain 
 UGC La Caleta Granada-Metropolitano, Andalusian Health Service, Av. del Sur, 11, 18014 Granada, Spain 
 Nursing Department, Faculty of Health Sciences, University of Castilla la Mancha, 02006 Albacete, Spain 
 Nursing Department, Faculty of Health Sciences, University of Granada, Cortadura del Valle s/n, 51001 Ceuta, Spain 
First page
3094
Publication year
2022
Publication date
2022
Publisher
MDPI AG
e-ISSN
20754418
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2756681529
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.